+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
| Target | SARS-CoV-2 Spike Protein RBD (Omicron B.1.1.529 Variant) |
| Research Area | Infection Immunity |
| Target Modification | Gly339Asp, Ser371Leu, Ser373Pro, Ser375Phe, Lys417Asn, Asn440Lys, Gly446Ser, Ser477Asn, Thr478Lys, Glu484Ala, Gln493Lys, Gly496Ser, Gln498Arg, Asn501Tyr, Tyr505His |
| Modification | Mutation |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | SDS-PAGE |
| Host | Mammalian cells |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Lyophilized |
| Purity | > 90% (SDS-PAGE) |
| Reconstitution | Reconstitute in ddH2O to a concentration of 1 mg/ml. |
| Storage | Store between -20°C and -80°C. Avoid repeated freeze/thaw cycles. |
| NCBI Accession | YP_009724390.1 |
| Molecular Weight | Observed MW: 35 kDa |
| Sequence | The exact sequnce is proprietary. |
| Tag | N-terminal His tag |
| Buffer | Prior to lyophilization: PBS, pH 7.5. |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |